A double-blind, placebo-controlled, multicenter study to examine the effects of finasteride 1 mg on serum prostate-specific antigen in men with androgenetic alopecia
Phase of Trial: Phase III
Latest Information Update: 08 Jan 2007
At a glance
- Drugs Finasteride (Primary)
- Indications Male pattern baldness
- Focus Pharmacodynamics
- Sponsors Merck & Co
- 08 Jan 2007 Results have been published.
- 21 Nov 2006 New trial record.